ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

IP

Institut Paoli-Calmettes at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Institut Paoli-Calmettes takes part in 10 sessions at ESMO 2026 in Madrid. Its sessions span treatment choices and precision care across cancers. They examine prostate cancer treatment guided by PSMA, treatment decisions for CLDN18.2-positive stomach cancer, and circulating tumour DNA in breast cancer.

OrganizationESMO 2026 Attendance
IP
Institut Paoli-Calmettes
Marseille, France
Cancer centre & hospital
Comprehensive cancer centre in Marseille, France, part of the Unicancer network of French cancer centres.
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
15:15–16:00
Circulating tumour DNA dynamics predicts treatment efficacy in metastatic triple-negative androgen receptor-positive breast cancer enrolled in the START phase II trial
Friday Poster Display session 2
Breast cancerSarcoma, CNS, head & neck and rare cancersBiomarkers & precision oncology
Satellite
Fri Oct 23
18:25–18:35
Unboxing first-line treatment choice
Astellas - Solving the puzzle: Optimising practice in CLDN18.2+ gastric/GEJ adenocarcinoma
Gastrointestinal cancers
Satellite
Fri Oct 23
18:35–18:45
Selecting your piece: CLDN18.2 targeted therapies
Astellas - Solving the puzzle: Optimising practice in CLDN18.2+ gastric/GEJ adenocarcinoma · with The Institute of Cancer Research, Hospital Universitario de Navarra, Hematology Oncology Practice Hamburg
Gastrointestinal cancers
Satellite
Fri Oct 23
18:55–19:10
The emerging picture: Precision medicine in clinical decision-making
Astellas - Solving the puzzle: Optimising practice in CLDN18.2+ gastric/GEJ adenocarcinoma · with Hematology Oncology Practice Hamburg, Hospital Universitario de Navarra, The Institute of Cancer Research
Gastrointestinal cancers
Satellite
Fri Oct 23
19:20–19:40
The complete picture: Enhancing patient care
Astellas - Solving the puzzle: Optimising practice in CLDN18.2+ gastric/GEJ adenocarcinoma · with Hospital Universitario de Navarra, The Institute of Cancer Research, Hematology Oncology Practice Hamburg
Gastrointestinal cancers
Poster
Sat Oct 24
12:00–12:45
Immune checkpoint inhibitor (ICI)–associated myocarditis: Is there room for ICI continuation or rechallenge?
Saturday Poster Display session 3
Nursing & supportive care
Satellite
Sat Oct 24
13:00–14:30
Satellite
Sat Oct 24
13:00–13:05
Welcome, introduction, and objectives for the session
Novartis - PSMA-targeted RLT in Prostate Cancer: Present and future
Genitourinary cancers
Satellite
Sat Oct 24
13:05–13:15
PSMA RLT in prostate cancer: What the guidelines say in 2026
Novartis - PSMA-targeted RLT in Prostate Cancer: Present and future
Genitourinary cancers
Satellite
Sat Oct 24
14:17–14:27
Future landscape in Prostate Cance
Novartis - PSMA-targeted RLT in Prostate Cancer: Present and future
Genitourinary cancers
Poster
Sun Oct 25
12:00–12:45
IMHOTEP phase II trial: 3-year follow-up
Sunday Poster Display session 4
Gastrointestinal cancersSarcoma, CNS, head & neck and rare cancers
Talk
Sun Oct 25
13:00–13:18
Mechanisms of action and synergies of electric fields with other anticancer modalities
ESMO Colloquium supported by Novocure GmbH - Electric field therapy devices for the treatment of cancer: Expanding treatment paradigms in solid tumour oncology
Talk
Mon Oct 26
10:15–10:20
Presentation of case/condition
Response-based adaptive strategies in primary metastatic kidney cancer
Genitourinary cancers
Talk
Mon Oct 26
10:40–11:00
What to do with the primary in extreme responders
Response-based adaptive strategies in primary metastatic kidney cancer
Genitourinary cancers
Abstract
Mon Oct 26
16:54–17:06

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Institut Paoli-Calmettes

Tell us what you sell and we’ll find the people at Institut Paoli-Calmettes most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction